France Pietri-Rouxel

Title: France Pietri-Rouxel: Innovator in Gene Therapy

Introduction

France Pietri-Rouxel is a notable inventor based in Clichy la Garenne, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of Duchenne muscular dystrophy (DMD). His innovative work has the potential to improve the lives of many affected by this condition.

Latest Patents

France Pietri-Rouxel holds 1 patent for his invention titled "Effective gene therapy tools for dystrophin exon 53 skipping." This invention involves a recombinant adeno-associated viral vector (rAAV) that encodes an antisense oligonucleotide (AON) targeting a specific segment of the dystrophin pre-messenger RNA. The application of this technology is particularly aimed at developing a drug for the treatment of DMD.

Career Highlights

France Pietri-Rouxel is associated with Genethon, a company dedicated to advancing gene therapy research and development. His work at Genethon has positioned him as a key player in the field, contributing to groundbreaking advancements in therapeutic approaches for genetic disorders.

Collaborations

France collaborates with Virginie Francois, who is also a prominent figure in the field. Their partnership exemplifies the collaborative spirit that drives innovation in gene therapy.

Conclusion

France Pietri-Rouxel's contributions to gene therapy, particularly through his patent for dystrophin exon 53 skipping, highlight his role as an innovator in the medical field. His work continues to pave the way for new treatments for genetic disorders, showcasing the importance of innovation in healthcare.